Cart 0

Atlas Group Leadership team

Ingela Hofverberg

Group Chief Executive Officer and CEO Atlas Antibodies

Ingela Hofverberg joined Atlas Antibodies from her role as Head of Lean & Transformation in SAS where she spent the last 6 years driving operational excellence through people and culture. Ingela is a highly experienced, driven, and passionate leader with more than 15 years of working with business transformation whereof 10 of them in Scania in various roles and parts of the organisation. Ingela has designed and implemented management systems and structures founded on Lean values and principles. Ingela holds an M.Sc. in Economics and Business Administration from Stockholm School of Economics partly completed at Darden Business School at University of Virginia.

Colin Tristram

CEO HistoCyte

Colin Tristram has over 20 years’ experience in the in vitro diagnostics field having started with developing monoclonal antibodies for tissue diagnostics at Novocastra Laboratories. Acquired by Vision BioSystems, he subsequently went on to roles in sales and marketing supporting a rapidly growing business globally with their Bond automated IHC/ISH platform. This was in turn acquired by Danaher and incorporated into Leica Biosystems. Mr. Tristram then created and headed an innovations group at their Advanced Staining site in Newcastle upon Tyne, looking at new technologies and diagnostic applications. In 2012 he left and started consulting, with which he funded and co-founded HistoCyte Laboratories developing and commercialising a range of IHC/ISH cell-based controls.

Stefan Schmidt

CEO evitria

Dr. Schmidt, joined evitria, after leading operations at BioAtrium, a JV of Lonza and Sanofi in Visp, Switzerland as COO. Previously he was CSO and held other senior executive roles at Rentschler Biopharma, Germany with overall responsibilities for biologics development and manufacturing. Before that, he was CSO at ERA Biotech in Barcelona, Spain, directing R&D efforts based on fusion proteins. Earlier he worked at AstraZeneca in Sweden where he led Protein Sciences within GPS&S as Associate Director. He started his leadership career more than 25 years ago in Munich, Germany where he built up biochemistry teams for Connex and GPC-Biotech. He holds a PhD in Biochemistry from the Julius Maximilians University in Wuerzburg, Germany and an MBA from the University in Gävle, Sweden.

Atlas Antibodies Management team

Catrine Siöberg, Ph.D.

Head of Research and Development

Catrine Siöberg joined Atlas Antibodies in 2022 to lead the Research and Development department. She holds a PhD in Medical Biochemistry at the Karolinska Institute and has long experience in the protein research field. Catrine has a strong innovation background and was one of the key-players in developing and commercializing the CETSA® method. She has extensive experience in building and leading research teams and as Chief Operating Officer at Pelago Bioscience AB, she established and scaled up a CRO business delivering research projects to the Pharma and Biotech industry.

Jonatan Blader

IT Manager

Jonatan Blader joined Atlas Antibodies in 2008 and has become a valuable team member. With over a decade of experience at the company, Jonatan has grown professionally and now holds the position of Manager since 2018. Leveraging his information technology expertise and strong leadership skills, he has played a pivotal role in developing the company's systems and driving strategic initiatives. Jonatan's dedication, strategic thinking, and technical acumen have contributed to the success and growth of Atlas Antibodies, making him an integral part of the organization.